Jump to content

All Article Types 2011


change article type:

Epichem Gains 51% Interest in JV for Development for New Treatment in Diabetes


Continue Reading...


PharmAust gains 51% interest in JV development of oral diabetic treatment

http://www.proactiveinvestors.com.au/companies/news/22639/pharmaust-gains-51-interest-in-jv-for-development-of-oral-diabetic-treatment--22639.html
Continue Reading...


PharmAust raises stake to 51% in JV with Curtain University

http://drugdiscovery.pharmaceutical-business-review.com/news/pharmaust-raises-stake-to-51-in-jv-with-curtin-university-281111
Continue Reading...


Earlier News

News Archives

2013 | 2012 | 2011 | 2010 | 2008 | 2007

This page was printed from the PharmAust website - visit us at http://www.pharmaust.com/